Studies
NHLBI TOPMed: Outcome Modifying Genes in Sickle Cell Disease (OMG)
NHLBI TOPMed: Outcome Modifying Genes in Sickle Cell Disease (OMG)
Request Access
Overview
Selected Publications (16)
Factors associated with survival in a contemporary adult sickle cell disease cohort
Hany Elmariah, M. Garrett, L. M. Castro, et al.. (2014). American Journal of Hematology. Cited 269 times.
https://doi.org/10.1002/ajh.23683
Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes
L. D. De Castro, Jude C Jonassaint, F. Graham, et al.. (2008). American Journal of Hematology. Cited 267 times.
https://doi.org/10.1002/ajh.21058
MYH9 and APOL1 are both associated with sickle cell disease nephropathy
A. Ashley-Koch, E. Okocha, M. Garrett, et al.. (2011). British Journal of Haematology. Cited 161 times.
https://doi.org/10.1111/j.1365-2141.2011.08832.x
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
N. Solovieff, J. Milton, Stephen W. Hartley, et al.. (2010). Blood. Cited 146 times.
https://doi.org/10.1182/blood-2009-08-239517
Genetic modifiers of the severity of sickle cell anemia identified through a genome‐wide association study
P. Sebastiani, N. Solovieff, Stephen W. Hartley, et al.. (2009). American Journal of Hematology. Cited 110 times.
https://doi.org/10.1002/ajh.21572
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
Harold Bae, C. Baldwin, P. Sebastiani, et al.. (2012). Blood. Cited 89 times.
https://doi.org/10.1182/blood-2012-06-432849
Genetic polymorphisms associated with priapism in sickle cell disease
L. Elliott, A. Ashley-Koch, L. D. Castro, et al.. (2007). British Journal of Haematology. Cited 74 times.
https://doi.org/10.1111/j.1365-2141.2007.06560.x
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival
M. Telen, A. Afenyi‐Annan, M. Garrett, et al.. (2015). Transfusion. Cited 73 times.
https://doi.org/10.1111/trf.12940
A Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia
J. Milton, P. Sebastiani, N. Solovieff, et al.. (2012). PLoS ONE. Cited 71 times.
https://doi.org/10.1371/journal.pone.0034741
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.
A. Ashley-Koch, L. Elliott, M. Kail, et al.. (2008). Blood. Cited 65 times.
https://doi.org/10.1182/blood-2007-02-074849
Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease
A. Afenyi‐Annan, M. Kail, M. R. Combs, et al.. (2008). Transfusion. Cited 65 times.
https://doi.org/10.1111/j.1537-2995.2007.01622.x
Surgical and obstetric outcomes in adults with sickle cell disease.
S. Adam, Jude C Jonassaint, H. Kruger, et al.. (2008). The American journal of medicine. Cited 51 times.
https://doi.org/10.1016/j.amjmed.2008.04.040
Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.
Geneviève Galarneau, S. Coady, M. Garrett, et al.. (2013). Blood. Cited 38 times.
https://doi.org/10.1182/blood-2013-01-478776
β2‐Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion
C. Eyler, Terry L. Jackson, L. Elliott, et al.. (2008). British Journal of Haematology. Cited 34 times.
https://doi.org/10.1111/j.1365-2141.2008.07008.x
Thrombospondin‐1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia
Seethal A Jacob, E. Novelli, J. Isenberg, et al.. (2017). American Journal of Hematology. Cited 12 times.
https://doi.org/10.1002/ajh.24635
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
A. Afenyi‐Annan, Allison Ashley-Koch, M. Telen. (2009). British Journal of Haematology. Cited 3 times.
https://doi.org/10.1111/j.1365-2141.2009.07588.x
